Chemical Class
Lysergamide
Psychoactive Class
Psychedelic
Receptor Profile
Receptor Actions
Agonists
5-HT2A receptor agonist (partial)
Other
prodrug of LSD
Effect Profile
Curated + 4 Reports
Psychedelic
5.4
Strong visuals with moderate body load, mild headspace
Visual Intensity×3
8
Headspace Depth×3
5
Auditory Effects×1
0
Body Load / Somatic Effects×1
6
Based on reports from:
Tolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Full tolerance
1h
Half tolerance
10d
Baseline
~14d
Cross-Tolerances
LSD
90%
●○○
Psilocybin
80%
●○○
Psilocin
80%
●○○
Mescaline
60%
●○○
DMT
80%
●○○
5-MeO-DMT
80%
●○○
2C-B
60%
●○○
2C-E
60%
●○○
Experience Report Analysis
Erowid
4
Reports
2022–2025
Date Range
4
With Age Data
5
Effects Detected
Demographics
Gender Distribution
Age Distribution
Reports Over Time
Effect Analysis
ErowidEffects aggregated from 4 experience reports (4 Erowid)
4
Reports
5
Effects Detected
2
Positive
1
Adverse
2
Neutral
Effect Sentiment Distribution
Confidence Distribution
Positive Effects 2
Music Enhancement
100.0%
70%
Stimulation
75.0%
70%
Adverse Effects 1
Anxiety
75.0%
70%
Form / Preparation
Most common forms and preparations reported
Legal Status
| Country | Status | Notes |
|---|---|---|
| Austria | According to the current legal situation, 1D-LSD is neither explicitly mentioned in the Narcotic Drugs Ordinance nor in the Psychotropic Substances Ordinance (SV/PV), thus it is neither to be classified as a narcotic drug in the sense of the SV nor as a psychotropic substance in the sense of the PV. | |
| Germany | Since the 14 June 2024 1D-LSD (and 1T-LSD) are covered by the German NpSG law. |
References
Data Sources
Cited References
- Bluelight: 1D-LSD Megathread
- Erowid: 1D-LSD Experience Reports
- Erowid Experience: Herald of the Long Unknown (150 ug 1D-LSD)
- Erowid Experience: Two Very Different Ego-Losses (1S-LSD & 1D-LSD)
- Human Psychopharmacology: Comparative study of LSD and LSD analogues
- Identification of 1-(thiophene-2-carbonyl)-LSD (1T-LSD) in blotters labelled 1D-LSD
- N1-acyl lysergamide prodrugs - review of abuse potential
- Okada et al. (2024): Synthesis & characterization of 1T-AL-LAD
- PsychonautWiki: Subjective Effect Index
- Reddit r/Drugs: 1D-LSD potency discussion
- Reddit r/LSD: 1D-LSD user survey (150 ug vs 225 ug)
- Sky News: Germany schedules 1D-LSD (June 14, 2024)
- N 1-acyl lysergamide prodrugs – review of abuse potential
- Reddit: first-time 1D-LSD report (faster onset, shorter trip)
- Ehrlich reagent discussion for 1D-LSD testing (Bluelight)